This guideline covers assessing and managing cancers of the upper aerodigestive tract in young people (aged 16 and over) and adults. It aims to reduce variation in practice and improve survival.
- information and support
- treatment of early and advanced stage disease
- HPV-related disease
- less common upper aerodigestive tract cancers
- optimising rehabilitation and function
- follow-up and treatment of late effects
Who is it for?
- People aged 16 and over with cancer of the upper aerodigestive tract, and their families and carers
- Healthcare professionals working in secondary and tertiary care
Is this guideline up to date?
We checked this guideline in July 2017. A partial update of the guideline will be planned. The update will focus on management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
Guideline development process
This version of the guideline contains the recommendations, context and recommendations for research. The Guideline Committee’s discussion and the evidence reviews are in the full guideline.
Other information about how the guideline was developed is on the project page. This includes the scope, and details of the Committee and any declarations of interest.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.
Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible.